Novavax Inc
(WBO:NVAX)
€
9.276
-0.09 (-0.96%)
Market Cap: 1.49 Bil
Enterprise Value: 734.28 Mil
PE Ratio: 0
PB Ratio: 0
GF Score: 47/100 Novavax Inc at Robert W Baird Global Healthcare Conference Transcript
Sep 12, 2023 / 02:15PM GMT
Joel Lawrence Beatty
Robert W. Baird & Co. Incorporated, Research Division - Senior Research Analyst
Good morning, everyone, and thank you for joining us for this next session of Baird's Healthcare Conference. And I'm really pleased that we have with us Novavax. And with us is Jim Kelly, CFO; and we also have Robert Walker, Chief Medical Officer. Guys, thank you so much for joining us.
James Patrick Kelly
Novavax, Inc. - Executive Vice President, CFO & Treasurer
Joel, thank you. Thank you very much and really appreciate you having us here today. Your timing is excellent. And I'm sure we'll jump into this in a minute with respect to some real-time activity happening at the ACIP meeting today. But before we get there, thanks again, and thanks for everyone for joining.
Questions & Answers
Joel Lawrence Beatty
Robert W. Baird & Co. Incorporated, Research Division - Senior Research Analyst
Exactly. I think you're right that this is my most real-time meeting of the conference. So this is really
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot